Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors

Breast cancer (BC) is the most common cancer in women. Although standard treatments are successful in patients with BC diagnosed at an early stage, an alternative treatment is required for patients with advanced-stage disease who do not respond to these treatments. The concept of using chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawasdee, Nunghathai, Wattanapanitch, Methichit, Thongsin, Nontaphat, Phanthaphol, Nattaporn, Chiawpanit, Chutipa, Thuwajit, Chanitra, Yenchitsomanus, Pa-Thai, Panya, Aussara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815410/
https://www.ncbi.nlm.nih.gov/pubmed/35119077
http://dx.doi.org/10.3892/ijmm.2022.5095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815410/
https://www.ncbi.nlm.nih.gov/pubmed/35119077
http://dx.doi.org/10.3892/ijmm.2022.5095

Ejemplares similares